Terminated PHASE2 INTERVENTIONAL 4-arm NCT02512679

Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells

Protocol for Related Donor Hematopoietic Stem Cell Transplantation (HSCT) for Treatment of Symptomatic Genetic Lymphohematological Diseases

Sponsor: Children's Hospital Los Angeles

Conditions Allogeneic Transplantation Bone Marrow Transplantation Chronic Granulomatous Disease Combined Immune Deficiency Diamond-Blackfan Anemia Genetic Diseases Metabolic Diseases Pediatrics Peripheral Blood Stem Cell Transplantation Stem Cell Transplantation Thalassemia Wiskott-Aldrich Syndrome X-linked Lymphoproliferative Disease

Interventions Cyclophosphamide Dose Level 1 Cyclophosphamide Dose Level 2 Cyclophosphamide Dose Level 3 Cyclophosphamide Dose Level 4

Updated 9 times since 2017 Last updated: Jan 12, 2017 Started: Feb 28, 2007 Primary completion: Sep 30, 2013 Completion: Feb 28, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Optimal dose obtained for engraftment and minimizing toxicity

Other terminated trials from Children's Hospital Los Angeles

See all terminations from Children's Hospital Los Angeles

Listed as NCT02512679, this PHASE2 trial focuses on Allogeneic Transplantation and Bone Marrow Transplantation and remains terminated or withdrawn. Sponsored by Children's Hospital Los Angeles, it has been updated 9 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2023 — Jul 2024 [monthly]

Terminated PHASE2
Dec 2022 — Jan 2023 [monthly]

Terminated PHASE2
Dec 2021 — Dec 2022 [monthly]

Terminated PHASE2

▶ Show 4 earlier versions

Jan 2021 — Dec 2021 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
May 2017 — Jun 2018 [monthly]

Terminated PHASE2
Jan 2017 — May 2017 [monthly]

Terminated PHASE2

First recorded

Feb 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Children's Hospital Los Angeles
Lucile Packard Children's Hospital

Data source: Children's Hospital Los Angeles

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.